Rapport Therapeutics Inc. Common Stock (RAPP) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Rapport Therapeutics Inc....

    NASDAQ: RAPP · Real-Time Price · USD
    28.54
    0.00 (0.00%)
    At close: Oct 03, 2025, 3:59 PM
    28.54
    0.00%
    After-hours: Oct 03, 2025, 04:10 PM EDT

    Rapport Therapeutics Common Stock Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Cash & Equivalents
    		 56.8M 70.17M 31.16M
    Short-Term Investments
    		 248.47M 77.31M n/a
    Long-Term Investments
    		 n/a n/a n/a
    Other Long-Term Assets
    		 160K 551K n/a
    Receivables
    		 n/a n/a n/a
    Inventory
    		 n/a n/a n/a
    Other Current Assets
    		 4.52M 3.31M 109K
    Total Current Assets
    		 309.8M 150.87M 31.27M
    Property-Plant & Equipment
    		 4.97M 4M 335K
    Goodwill & Intangibles
    		 n/a n/a n/a
    Total Long-Term Assets
    		 5.13M 4.55M 335K
    Total Assets
    		 314.93M 155.42M 31.6M
    Account Payables
    		 1.95M 2.5M 1.45M
    Deferred Revenue
    		 n/a n/a n/a
    Short-Term Debt
    		 737K 670K n/a
    Other Current Liabilities
    		 2.97M 2.55M n/a
    Total Current Liabilities
    		 8.77M 8.8M 1.66M
    Long-Term Debt
    		 n/a 4.2M 10.44M
    Other Long-Term Liabilities
    		 n/a n/a n/a
    Total Long-Term Liabilities
    		 739K 5.68M 10.44M
    Total Liabilities
    		 9.51M 14.48M 12.1M
    Total Debt
    		 1.48M 2.15M 10.44M
    Book Value
    		 305.43M 140.94M 19.5M
    Book Value Per Share
    		 1.47 0.78 0.10
    Common Stock
    		 37K 4K 31K
    Retained Earnings
    		 -123.75M -45.44M -10.65M
    Comprehensive Income
    		 -522K 4K -31K
    Shareholders Equity
    		 305.43M 140.94M 19.5M
    Total Investments
    		 248.47M 77.31M n/a

    Add to Watchlist